Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 130 of 1,261
  1. US 11932856

    RNA targeting of mutations via suppressor tRNAs and deaminases

    The Regents of the University of California Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  2. US 11931402

    Compositions for treating heart disease by inhibiting the action of mAKAP-Ξ²

    Anchored RSK3 Inhibitors, LLC Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  3. US 11931453

    Drug delivery device

    Nano Precision Medical, Inc. Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  4. US 11932692

    Methods of treating cancer pain by administering a PD-1 inhibitor

    REGENERON PHARMACEUTICALS, INC. Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  5. US 11932653

    Lycorine derivative, and pharmaceutical composition and use thereof

    BEIJING DYNE HIGH-TECH PEDIATRIC PHARMACEUTICAL R&D INSTITUTE CO., LTD. Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  6. US 11931336

    Enhancing autophagy or increasing longevity by administration of urolithins

    Amazentis SA Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  7. US 11932635

    CRBN ligands and uses thereof

    Kymera Therapeutics, Inc. Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  8. US 11931337

    Compound antioxidant preparation for reducing the number of somatic cells in a livestock animal and a preparation method and application thereof

    China Agricultural University Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  9. US 11931480

    Microporous annealed particle gels and methods of use

    The Regents of the University of California Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  10. US 11931375

    Treatment of amyotrophic lateral sclerosis (ALS)

    VOYAGER THERAPEUTICS, INC. Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  11. US 11932705

    Cyclic polypeptides for PCSK9 inhibition

    RA PHARMACEUTICALS, INC. Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  12. US 11933781

    Fibrosis model and methods of use thereof

    The Regents of the University of Colorado Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  13. US 11932852

    Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof

    Benitec IP Holdings Inc. Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  14. US 11933866

    Magnetic resonance maps for analyzing brain tissue

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. Β· Granted Mar 19, 2024 Β· Expires Mar 14, 2044

    granted
  15. WO 2024052517

    USAGE MÉDICAL D'ANTICORPS ANTI-CCR8 ET PROGRAMME DE DOSAGE

    BAYER AG [DE] Β· Granted Mar 14, 2024 Β· Expires Mar 9, 2044

    granted
  16. KR 20240034693

    μ΄λŸ‰μ²΄ 쑰영제의 제쑰

    BRACCO IMAGING SPA [IT] Β· Granted Mar 14, 2024 Β· Expires Mar 9, 2044

    granted
  17. US 11926622

    Fluoroalkyl-oxadiazoles and uses thereof

    Tenaya Therapeutics, Inc. Β· Granted Mar 12, 2024 Β· Expires Mar 7, 2044

    granted
  18. US 11925669

    Chinese herbal medicine composition having a function of reducing uric acid

    INFINITUS (CHINA) COMPANY LTD. Β· Granted Mar 12, 2024 Β· Expires Mar 7, 2044

    granted
  19. US 11925685

    DNA antibody constructs encoding anti-ZIKV envelope antibodies

    Inovio Pharmaceuticals, Inc. Β· Granted Mar 12, 2024 Β· Expires Mar 7, 2044

    granted
  20. US 11926826

    Twist signaling inhibitor compositions and methods of using the same

    The Regents of the University of California Β· Granted Mar 12, 2024 Β· Expires Mar 7, 2044

    granted
  21. US 11925642

    Regulation of eIF4E activity for migraine therapy

    The Board of Regents of the University of Texas System Β· Granted Mar 12, 2024 Β· Expires Mar 7, 2044

    granted
  22. US 11926584

    Methods of making bempedoic acid and compositions of the same

    Esperion Therapeutics, Inc. Β· Granted Mar 12, 2024 Β· Expires Mar 7, 2044

    granted
  23. US 11925629

    Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer

    Asana BioSciences, LLC Β· Granted Mar 12, 2024 Β· Expires Mar 7, 2044

    granted
  24. US 11925664

    Intracellular genomic transplant and methods of therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Mar 12, 2024 Β· Expires Mar 7, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.